Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNORD23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SVBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPUSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VRK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOSIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COTL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAGC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INTS9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIPAS39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRNAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAAA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP36L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on